Epidemiologic factors in patients with advanced head and neck cancer treated with radiation therapy

Michael T Brennan, Nathaniel S Treister, Thomas P Sollecito, Brian L Schmidt, Lauren L Patton, Yi Yang, Alexander Lin, Linda S Elting, James S Hodges, Rajesh V Lalla, Michael T Brennan, Nathaniel S Treister, Thomas P Sollecito, Brian L Schmidt, Lauren L Patton, Yi Yang, Alexander Lin, Linda S Elting, James S Hodges, Rajesh V Lalla

Abstract

Background: Approximately 50% of patients with head and neck cancer (HNC) initially were seen with advanced disease. We aimed to evaluate the association of epidemiologic factors with advanced HNC at diagnosis.

Methods: The OraRad multicenter prospective cohort study enrolled HNC patients receiving curative-intent radiation therapy. Factors assessed for association with advanced HNC presentation at diagnosis included demographics, social and medical history, cancer characteristics, human papilloma virus (HPV) status, and dental disease measures.

Results: We enrolled 572 participants; 77% male and mean (SD) age of 61.7 (11.2) years. Oropharyngeal squamous cell carcinomas (88% HPV-related) were seen with smaller tumors, but more frequent nodal involvement. Private medical insurance and no Medicaid were associated with smaller tumors. A higher dental disease burden was associated with larger tumors.

Conclusions: Insurance status, cancer type/location, and dental disease are associated with advanced HNC and may represent potentially modifiable factors or factors to be considered in the screening process of new lesions.

Keywords: baseline features; dental health; epidemiology; head and neck cancer; radiotherapy.

Conflict of interest statement

The authors declare no conflicts of interest.

© 2020 The Authors. Head & Neck published by Wiley Periodicals LLC.

References

    1. American Cancer Society . Cancer Facts & Figures 2017. Atlanta, GA: American Cancer Society; 2017.
    1. Choi SH, Terrell JE, Fowler KE, et al. Socioeconomic and other demographic disparities predicting survival among head and neck cancer patients. PLoS One. 2016;11(3):e0149886.
    1. Adrien J, Bertolus C, Gambotti L, Mallet A, Baujat B. Why are head and neck squamous cell carcinoma diagnosed so late? Influence of health care disparities and socio‐economic factors. Oral Oncol. 2014;50(2):90‐97.
    1. American Joint Committee on Cancer . In: Edge SB, Byrd DR, Compton CC, et al., eds. AJCC Cancer Staging Manual. Chicago, IL: American Joint Committee on Cancer; 2010. .
    1. Farquhar DR, Tanner AM, Masood MM, et al. Oral tongue carcinoma among young patients: an analysis of risk factors and survival. Oral Oncol. 2018;84:7‐11.
    1. Simpson MC, Challapalli SD, Cass LM, et al. Impact of gender on the association between marital status and head and neck cancer outcomes. Oral Oncol. 2019;89:48‐55.
    1. Gourin CG, Podolsky RH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope. 2006;116(7):1093‐1106.
    1. Lebo NL, Khalil D, Balram A, et al. Influence of socioeconomic status on stage at presentation of laryngeal cancer in the United States. Otolaryngol Head Neck Surg. 2019;161(5):800‐806.
    1. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83(4):489‐501.
    1. Lalla RV, Long‐Simpson L, Hodges JS, et al. Clinical registry of dental outcomes in head and neck cancer patients (OraRad): rationale, methods, and recruitment considerations. BMC Oral Health. 2017;17(1):59.
    1. National Cancer Institute. Cancer Stat Facts: Oral Cavity and Pharynx Cancer.
    1. Hashim D, Sartori S, Brennan P, et al. The role of oral hygiene in head and neck cancer: results from international head and neck cancer epidemiology (INHANCE) consortium. Ann Oncol. 2016;27(8):1619‐1625.
    1. Chang JS, Lo HI, Wong TY, et al. Investigating the association between oral hygiene and head and neck cancer. Oral Oncol. 2013;49(10):1010‐1017.
    1. Velly AM, Franco EL, Schlecht N, et al. Relationship between dental factors and risk of upper aerodigestive tract cancer. Oral Oncol. 1998;34(4):284‐291.
    1. Rosenquist K, Wennerberg J, Schildt EB, Bladström A, Göran Hansson B, Andersson G. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population‐based case‐control study in southern Sweden. Acta Otolaryngol. 2005;125(12):1327‐1336.
    1. Smith EM, Ritchie JM, Summersgill KF, et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer. 2004;108(5):766‐772.
    1. Hong AM, Martin A, Chatfield M, et al. Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. Int J Cancer. 2013;132(12):2748‐2754.
    1. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16‐positive and human papillomavirus type 16‐negative head and neck cancers. J Natl Cancer Inst. 2008;100(6):407‐420.
    1. O'Sullivan B, Huang SH, Perez‐Ordonez B, et al. Outcomes of HPV‐related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol. 2012;103(1):49‐56.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere